Myelography in healthy dogs using ioversol 240 mg I/ml contrast medium: Clinical and radiological results
Autor(a) principal: | |
---|---|
Data de Publicação: | 2001 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Veterinary Research and Animal Science |
Texto Completo: | https://www.revistas.usp.br/bjvras/article/view/5910 |
Resumo: | This study aimed to assess the opacification period and diagnostic quality of ioversol 240 mg I/ml in the thoracic and lumbar regions after intracisternally injected, and evaluate its effects on the nervous system by clinical and neurological examinations. Thirty clinically normal non-descript dogs without sex distinction, weighing 9-12 kg were divided into three groups of 10 animals each. All the animals were anaesthetized using diazepam and thiopental sodium. Ioversol was injected at a dose of 0.5ml/kg. Cervical radiographs after 5 minutes to confirm injection of the contrast, and thoracolumbar radiographs after 30, 40, 50 and 60 minutes to evaluate the opacification period were taken. Clinical and neurological examinations were performed daily until 7, 14 and 28 days for groups I, II and III respectively. Adverse reactions such as pedal movements, preconvulsive behavior, muscular spasms, apnea, dyspnea, and vomit anxiety were observed during the myelographic procedure only. Ioversol showed good radiopacity, diffusion and miscibility with the cerebrospinal fluid. Reduction of costs also was possible since it can be autoclaved. Opacification period with diagnostic value was of 60 minutes in 60% of thoracic radiographs and in 80% of lumbar radiographs. Ioversol showed low incidence of clinical and neurological alterations. It is concluded that ioversol 240 mg I/ml is appropriate and safe to be used for myelography in dogs. |
id |
USP-49_138a10b5589a9cc69b8ebf1d6e7d8bbf |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/5910 |
network_acronym_str |
USP-49 |
network_name_str |
Brazilian Journal of Veterinary Research and Animal Science |
repository_id_str |
https://www.revistas.usp.br/bjvras/index |
spelling |
Myelography in healthy dogs using ioversol 240 mg I/ml contrast medium: Clinical and radiological resultsMielografia em cães sadios com o meio de contraste ioversol 240 mg I/ml: Resultados clínicos e radiológicosMielografiaCãesMeios de contrasteMyelographyDogsContrast mediaThis study aimed to assess the opacification period and diagnostic quality of ioversol 240 mg I/ml in the thoracic and lumbar regions after intracisternally injected, and evaluate its effects on the nervous system by clinical and neurological examinations. Thirty clinically normal non-descript dogs without sex distinction, weighing 9-12 kg were divided into three groups of 10 animals each. All the animals were anaesthetized using diazepam and thiopental sodium. Ioversol was injected at a dose of 0.5ml/kg. Cervical radiographs after 5 minutes to confirm injection of the contrast, and thoracolumbar radiographs after 30, 40, 50 and 60 minutes to evaluate the opacification period were taken. Clinical and neurological examinations were performed daily until 7, 14 and 28 days for groups I, II and III respectively. Adverse reactions such as pedal movements, preconvulsive behavior, muscular spasms, apnea, dyspnea, and vomit anxiety were observed during the myelographic procedure only. Ioversol showed good radiopacity, diffusion and miscibility with the cerebrospinal fluid. Reduction of costs also was possible since it can be autoclaved. Opacification period with diagnostic value was of 60 minutes in 60% of thoracic radiographs and in 80% of lumbar radiographs. Ioversol showed low incidence of clinical and neurological alterations. It is concluded that ioversol 240 mg I/ml is appropriate and safe to be used for myelography in dogs.Este trabalho teve por objetivo avaliar o período de opacificação e a qualidade diagnóstica do ioversol 240 mg I/ml, nas regiões torácica e lombar após sua injeção na cisterna magna, e verificar seus efeitos sobre o sistema nervoso por meio de observações clínicas e neurológicas. Utilizaram-se 30 cães sadios, sem distinção de sexo ou raça, com peso entre 9 e 12 kg, divididos em três grupos de 10 animais cada. Nos animais anestesiados com diazepam e tiopental sódico, o ioversol foi injetado na dose de 0,5 ml/kg. Foram obtidas radiografias cervicais aos cinco minutos para confirmar a injeção do contraste e toracolombares aos 30, 40, 50 e 60 minutos para avaliar o período de opacificação. Exames clínicos e neurológicos foram realizados diariamente até os 7, 14 e 28 dias para os grupos I, II e III respectivamente. Efeitos adversos como movimentos de pedalagem, início de convulsão, espasmos musculares, apnéia, dispnéia e ânsia de vômito foram observados apenas durante o procedimento mielográfico. O ioversol apresentou boas radiopacidade, difusão e miscibilidade com o líquor, oferecendo também a possibilidade de redução de custos, já que pode ser autoclavado. O tempo de opacificação do contraste com valor diagnóstico atingiu 60 minutos em 60% das radiografias torácicas e em 80% das radiografias lombares. Havendo baixa incidência de alterações clínicas e neurológicas, e apropriadas qualidades radiográficas, concluiu-se que o ioversol na concentração de 240 mg I/ml é adequado e seguro para ser utilizado em mielografia de cães.Universidade de São Paulo. Faculdade de Medicina Veterinária e Zootecnia2001-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjvras/article/view/591010.1590/S1413-95962001000200010Brazilian Journal of Veterinary Research and Animal Science; Vol. 38 Núm. 2 (2001); 97-100Brazilian Journal of Veterinary Research and Animal Science; Vol. 38 No. 2 (2001); 97-100Brazilian Journal of Veterinary Research and Animal Science; v. 38 n. 2 (2001); 97-100Brazilian Journal of Veterinary Research and Animal Science; V. 38 N. 2 (2001); 97-1001678-44561413-9596reponame:Brazilian Journal of Veterinary Research and Animal Scienceinstname:Faculdade de Medicina Veterinária e Zootecnia da Universidade de São Paulo (FMVZ-USP)instacron:USPenghttps://www.revistas.usp.br/bjvras/article/view/5910/7441Sarmento, Luciana Virgínia CostaTudury, Eduardo AlbertoCaldas, Eduardo Luiz CavalcantiMagalhães, Patrícia Karla de LunaAlbuquerque, Éricka Rejane Correiainfo:eu-repo/semantics/openAccess2020-06-23T04:38:46Zoai:revistas.usp.br:article/5910Revistahttps://www.revistas.usp.br/bjvrasPUBhttps://www.revistas.usp.br/bjvras/oaibjvras@usp.br1413-95961413-9596opendoar:https://www.revistas.usp.br/bjvras/index2023-01-12T16:42:28.990335Brazilian Journal of Veterinary Research and Animal Science - Faculdade de Medicina Veterinária e Zootecnia da Universidade de São Paulo (FMVZ-USP)false |
dc.title.none.fl_str_mv |
Myelography in healthy dogs using ioversol 240 mg I/ml contrast medium: Clinical and radiological results Mielografia em cães sadios com o meio de contraste ioversol 240 mg I/ml: Resultados clínicos e radiológicos |
title |
Myelography in healthy dogs using ioversol 240 mg I/ml contrast medium: Clinical and radiological results |
spellingShingle |
Myelography in healthy dogs using ioversol 240 mg I/ml contrast medium: Clinical and radiological results Sarmento, Luciana Virgínia Costa Mielografia Cães Meios de contraste Myelography Dogs Contrast media |
title_short |
Myelography in healthy dogs using ioversol 240 mg I/ml contrast medium: Clinical and radiological results |
title_full |
Myelography in healthy dogs using ioversol 240 mg I/ml contrast medium: Clinical and radiological results |
title_fullStr |
Myelography in healthy dogs using ioversol 240 mg I/ml contrast medium: Clinical and radiological results |
title_full_unstemmed |
Myelography in healthy dogs using ioversol 240 mg I/ml contrast medium: Clinical and radiological results |
title_sort |
Myelography in healthy dogs using ioversol 240 mg I/ml contrast medium: Clinical and radiological results |
author |
Sarmento, Luciana Virgínia Costa |
author_facet |
Sarmento, Luciana Virgínia Costa Tudury, Eduardo Alberto Caldas, Eduardo Luiz Cavalcanti Magalhães, Patrícia Karla de Luna Albuquerque, Éricka Rejane Correia |
author_role |
author |
author2 |
Tudury, Eduardo Alberto Caldas, Eduardo Luiz Cavalcanti Magalhães, Patrícia Karla de Luna Albuquerque, Éricka Rejane Correia |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Sarmento, Luciana Virgínia Costa Tudury, Eduardo Alberto Caldas, Eduardo Luiz Cavalcanti Magalhães, Patrícia Karla de Luna Albuquerque, Éricka Rejane Correia |
dc.subject.por.fl_str_mv |
Mielografia Cães Meios de contraste Myelography Dogs Contrast media |
topic |
Mielografia Cães Meios de contraste Myelography Dogs Contrast media |
description |
This study aimed to assess the opacification period and diagnostic quality of ioversol 240 mg I/ml in the thoracic and lumbar regions after intracisternally injected, and evaluate its effects on the nervous system by clinical and neurological examinations. Thirty clinically normal non-descript dogs without sex distinction, weighing 9-12 kg were divided into three groups of 10 animals each. All the animals were anaesthetized using diazepam and thiopental sodium. Ioversol was injected at a dose of 0.5ml/kg. Cervical radiographs after 5 minutes to confirm injection of the contrast, and thoracolumbar radiographs after 30, 40, 50 and 60 minutes to evaluate the opacification period were taken. Clinical and neurological examinations were performed daily until 7, 14 and 28 days for groups I, II and III respectively. Adverse reactions such as pedal movements, preconvulsive behavior, muscular spasms, apnea, dyspnea, and vomit anxiety were observed during the myelographic procedure only. Ioversol showed good radiopacity, diffusion and miscibility with the cerebrospinal fluid. Reduction of costs also was possible since it can be autoclaved. Opacification period with diagnostic value was of 60 minutes in 60% of thoracic radiographs and in 80% of lumbar radiographs. Ioversol showed low incidence of clinical and neurological alterations. It is concluded that ioversol 240 mg I/ml is appropriate and safe to be used for myelography in dogs. |
publishDate |
2001 |
dc.date.none.fl_str_mv |
2001-01-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/bjvras/article/view/5910 10.1590/S1413-95962001000200010 |
url |
https://www.revistas.usp.br/bjvras/article/view/5910 |
identifier_str_mv |
10.1590/S1413-95962001000200010 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/bjvras/article/view/5910/7441 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Medicina Veterinária e Zootecnia |
publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Medicina Veterinária e Zootecnia |
dc.source.none.fl_str_mv |
Brazilian Journal of Veterinary Research and Animal Science; Vol. 38 Núm. 2 (2001); 97-100 Brazilian Journal of Veterinary Research and Animal Science; Vol. 38 No. 2 (2001); 97-100 Brazilian Journal of Veterinary Research and Animal Science; v. 38 n. 2 (2001); 97-100 Brazilian Journal of Veterinary Research and Animal Science; V. 38 N. 2 (2001); 97-100 1678-4456 1413-9596 reponame:Brazilian Journal of Veterinary Research and Animal Science instname:Faculdade de Medicina Veterinária e Zootecnia da Universidade de São Paulo (FMVZ-USP) instacron:USP |
instname_str |
Faculdade de Medicina Veterinária e Zootecnia da Universidade de São Paulo (FMVZ-USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Brazilian Journal of Veterinary Research and Animal Science |
collection |
Brazilian Journal of Veterinary Research and Animal Science |
repository.name.fl_str_mv |
Brazilian Journal of Veterinary Research and Animal Science - Faculdade de Medicina Veterinária e Zootecnia da Universidade de São Paulo (FMVZ-USP) |
repository.mail.fl_str_mv |
bjvras@usp.br |
_version_ |
1797051555770269696 |